Title : Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling - Suciu_2018_ACS.Med.Chem.Lett_9_563 |
Author(s) : Suciu RM , Cognetta AB, 3rd , Potter ZE , Cravatt BF |
Ref : ACS Med Chem Lett , 9 :563 , 2018 |
Abstract :
Wnt proteins are secreted morphogens that play critical roles in embryonic development and tissue remodeling in adult organisms. Aberrant Wnt signaling contributes to diseases such as cancer. Wnts are modified by an unusual O-fatty acylation event (O-linked palmitoleoylation of a conserved serine) that is required for binding to Frizzled receptors. O-Palmitoleoylation of Wnts is introduced by the porcupine (PORCN) acyltransferase and removed by the serine hydrolase NOTUM. PORCN inhibitors are under development for oncology, while NOTUM inhibitors have potential for treating degenerative diseases. Here, we describe the use of activity-based protein profiling (ABPP) to discover and advance a class of N-hydroxyhydantoin (NHH) carbamates that potently and selectively inhibit NOTUM. An optimized NHH carbamate inhibitor, ABC99, preserves Wnt-mediated cell signaling in the presence of NOTUM and was also converted into an ABPP probe for visualizing NOTUM in native biological systems. |
PubMedSearch : Suciu_2018_ACS.Med.Chem.Lett_9_563 |
PubMedID: 29937983 |
Gene_locus related to this paper: human-NOTUM |
Inhibitor | ABC99 |
Gene_locus | human-NOTUM |
Suciu RM, Cognetta AB, 3rd, Potter ZE, Cravatt BF (2018)
Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling
ACS Med Chem Lett
9 :563
Suciu RM, Cognetta AB, 3rd, Potter ZE, Cravatt BF (2018)
ACS Med Chem Lett
9 :563